DK3093345T3 - BACULOVIRUS VECTORS INCLUDING REPEATED CODING SEQUENCES WITH DIFFERENTIAL PREFERRED CODES - Google Patents
BACULOVIRUS VECTORS INCLUDING REPEATED CODING SEQUENCES WITH DIFFERENTIAL PREFERRED CODES Download PDFInfo
- Publication number
- DK3093345T3 DK3093345T3 DK16176100.2T DK16176100T DK3093345T3 DK 3093345 T3 DK3093345 T3 DK 3093345T3 DK 16176100 T DK16176100 T DK 16176100T DK 3093345 T3 DK3093345 T3 DK 3093345T3
- Authority
- DK
- Denmark
- Prior art keywords
- coding sequences
- baculovirus vectors
- vectors including
- including repeated
- repeated coding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/864—Parvoviral vectors, e.g. parvovirus, densovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14044—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/50—Vectors for producing vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95208107P | 2007-07-26 | 2007-07-26 | |
EP07113257 | 2007-07-26 | ||
EP08779058.0A EP2173888B1 (en) | 2007-07-26 | 2008-07-25 | Baculoviral vectors comprising repeated coding sequences with differential codon biases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3093345T3 true DK3093345T3 (en) | 2019-06-24 |
Family
ID=38753583
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08779058.0T DK2173888T3 (en) | 2007-07-26 | 2008-07-25 | Baculovirus vectors comprising repeating coding sequences WITH differential preferred codons |
DK16176100.2T DK3093345T3 (en) | 2007-07-26 | 2008-07-25 | BACULOVIRUS VECTORS INCLUDING REPEATED CODING SEQUENCES WITH DIFFERENTIAL PREFERRED CODES |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08779058.0T DK2173888T3 (en) | 2007-07-26 | 2008-07-25 | Baculovirus vectors comprising repeating coding sequences WITH differential preferred codons |
Country Status (20)
Country | Link |
---|---|
US (5) | US8697417B2 (en) |
EP (3) | EP2173888B1 (en) |
JP (2) | JP5634262B2 (en) |
KR (1) | KR101597695B1 (en) |
CN (1) | CN101868547B (en) |
AU (1) | AU2008279883B2 (en) |
BR (1) | BRPI0814459B1 (en) |
CA (1) | CA2694406C (en) |
DK (2) | DK2173888T3 (en) |
EA (1) | EA022169B1 (en) |
ES (1) | ES2602585T3 (en) |
HK (1) | HK1143185A1 (en) |
HU (1) | HUE029744T2 (en) |
IL (1) | IL203535A (en) |
MX (1) | MX2010000944A (en) |
NZ (1) | NZ582881A (en) |
PL (2) | PL3093345T3 (en) |
PT (1) | PT2173888T (en) |
SI (2) | SI3093345T1 (en) |
WO (1) | WO2009014445A2 (en) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2173888T (en) * | 2007-07-26 | 2016-11-17 | Uniqure Ip Bv | Baculoviral vectors comprising repeated coding sequences with differential codon biases |
GB0911870D0 (en) | 2009-07-08 | 2009-08-19 | Ucl Business Plc | Optimised coding sequence and promoter |
EP3792348A3 (en) | 2010-03-11 | 2021-06-23 | uniQure IP B.V. | Mutated rep encoding sequences for use in aav production |
WO2011122950A1 (en) | 2010-04-01 | 2011-10-06 | Amsterdam Molecular Therapeutics (Amt) Ip B.V. | Monomeric duplex aav vectors |
IT1400425B1 (en) | 2010-06-08 | 2013-05-31 | Amsterdam Molecular Therapeutics Bv | MODIFIED SNRNAS FOR USE IN THERAPY. |
US20140155469A1 (en) | 2011-04-19 | 2014-06-05 | The Research Foundation Of State University Of New York | Adeno-associated-virus rep sequences, vectors and viruses |
GB201210357D0 (en) | 2012-06-12 | 2012-07-25 | Ucl Business Plc | Factor VIII sequences |
WO2015060722A1 (en) | 2013-10-24 | 2015-04-30 | Uniqure Ip B.V. | Aav-5 pseudotyped vector for gene therapy for neurological diseases |
KR102572449B1 (en) | 2014-03-10 | 2023-08-31 | 유니큐어 아이피 비.브이. | Further improved aav vectors produced in insect cells |
WO2015191508A1 (en) | 2014-06-09 | 2015-12-17 | Voyager Therapeutics, Inc. | Chimeric capsids |
JP6401871B2 (en) | 2014-11-05 | 2018-10-10 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | AADC polynucleotide for the treatment of Parkinson's disease |
GB201420139D0 (en) | 2014-11-12 | 2014-12-24 | Ucl Business Plc | Factor IX gene therapy |
EP3218484A4 (en) | 2014-11-14 | 2018-05-30 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
SG11201703419UA (en) | 2014-11-14 | 2017-05-30 | Voyager Therapeutics Inc | Modulatory polynucleotides |
HUE046643T2 (en) | 2014-11-28 | 2021-11-29 | Uniqure Ip Bv | Dna impurities in a composition comprising a parvoviral virion |
EP3230441A4 (en) | 2014-12-12 | 2018-10-03 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
PT3237618T (en) | 2014-12-24 | 2019-07-04 | Uniqure Ip Bv | Rnai induced huntingtin gene suppression |
CN108699567B (en) * | 2016-04-21 | 2024-02-13 | 威洛克有限公司 | AAV production in insect cells, methods and compositions |
EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
WO2017189964A2 (en) | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
WO2017201258A1 (en) | 2016-05-18 | 2017-11-23 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
EP3458588A4 (en) | 2016-05-18 | 2020-01-15 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
PE20190401A1 (en) | 2016-07-26 | 2019-03-13 | Biomarin Pharm Inc | NOVEL CAPSID PROTEINS FROM THE ADENO-ASSOCIATED VIRUS |
US20190185864A1 (en) | 2016-08-23 | 2019-06-20 | Akouos, Inc. | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
EP3831281A1 (en) | 2016-08-30 | 2021-06-09 | The Regents of The University of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
EP3554579A1 (en) | 2016-12-16 | 2019-10-23 | uniQure IP B.V. | Immunoadsorption |
JP2020518258A (en) | 2017-05-05 | 2020-06-25 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | Amyotrophic lateral sclerosis (ALS) treatment composition and method |
WO2018204803A1 (en) | 2017-05-05 | 2018-11-08 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
JOP20190269A1 (en) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | Aadc polynucleotides for the treatment of parkinson's disease |
KR20200041310A (en) | 2017-07-10 | 2020-04-21 | 유니큐어 아이피 비.브이. | Means and methods for AAA gene therapy in humans |
US11497576B2 (en) | 2017-07-17 | 2022-11-15 | Voyager Therapeutics, Inc. | Trajectory array guide system |
EP3808849A1 (en) | 2017-08-03 | 2021-04-21 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
WO2019079242A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
AU2018352236A1 (en) | 2017-10-16 | 2020-04-23 | The Curators Of The University Of Missouri | Treatment of amyotrophic lateral sclerosis (ALS) |
WO2019129859A1 (en) | 2017-12-29 | 2019-07-04 | Uniqure Ip B.V. | Modified viral vectors and methods of making and using the same |
KR20200135768A (en) | 2018-01-17 | 2020-12-03 | 메이라지티엑스 유케이 Ii 리미티드 | Modified rAAV capsid protein for gene therapy |
TW202015742A (en) | 2018-05-15 | 2020-05-01 | 美商航海家醫療公司 | Compositions and methods for delivery of aav |
EP3807404A1 (en) | 2018-06-13 | 2021-04-21 | Voyager Therapeutics, Inc. | Engineered 5' untranslated regions (5' utr) for aav production |
JP2021529513A (en) | 2018-07-02 | 2021-11-04 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | Treatment of amyotrophic lateral sclerosis and spinal cord-related disorders |
EP3826719A1 (en) | 2018-07-24 | 2021-06-02 | Voyager Therapeutics, Inc. | Systems and methods for producing gene therapy formulations |
US10842885B2 (en) | 2018-08-20 | 2020-11-24 | Ucl Business Ltd | Factor IX encoding nucleotides |
EP3850098A1 (en) | 2018-09-12 | 2021-07-21 | uniQure IP B.V. | Rnai induced c9orf72 suppression for the treatment of als/ftd |
US20220125073A1 (en) * | 2018-09-20 | 2022-04-28 | Tallgrass Biologics L.L.C. | Treatment and control of colony collapse disorder |
CN109295172A (en) * | 2018-09-26 | 2019-02-01 | 浙江海洋大学 | The codon preference analysis method of Larimichthys crocea scavenger receptor family gene |
AU2019346655A1 (en) | 2018-09-28 | 2021-05-06 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
TW202035689A (en) | 2018-10-04 | 2020-10-01 | 美商航海家醫療公司 | Methods for measuring the titer and potency of viral vector particles |
SG11202103425YA (en) | 2018-10-05 | 2021-05-28 | Voyager Therapeutics Inc | Engineered nucleic acid constructs encoding aav production proteins |
WO2020077165A1 (en) | 2018-10-12 | 2020-04-16 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
WO2020081490A1 (en) | 2018-10-15 | 2020-04-23 | Voyager Therapeutics, Inc. | EXPRESSION VECTORS FOR LARGE-SCALE PRODUCTION OF rAAV IN THE BACULOVIRUS/Sf9 SYSTEM |
WO2020104295A1 (en) | 2018-11-19 | 2020-05-28 | Uniqure Ip B.V. | Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3 |
EP3884067A1 (en) | 2018-11-19 | 2021-09-29 | uniQure IP B.V. | A companion diagnostic to monitor the effects of gene therapy |
WO2020104469A1 (en) | 2018-11-19 | 2020-05-28 | Uniqure Ip B.V. | Method and means to deliver mirna to target cells |
WO2020104480A1 (en) | 2018-11-19 | 2020-05-28 | Uniqure Biopharma B.V. | Adeno-associated virus vectors for expressing fviii mimetics and uses thereof |
US20220064671A1 (en) | 2019-01-18 | 2022-03-03 | Voyager Therapeutics, Inc. | Methods and systems for producing aav particles |
WO2020223274A1 (en) | 2019-04-29 | 2020-11-05 | Voyager Therapeutics, Inc. | SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS |
CN114502737A (en) | 2019-07-15 | 2022-05-13 | 梅里特斯英国第二有限公司 | Modified AAV capsid proteins for the treatment of arthritic diseases |
EP4010465A1 (en) | 2019-08-09 | 2022-06-15 | Voyager Therapeutics, Inc. | Cell culture medium for use in producing gene therapy products in bioreactors |
WO2021041375A1 (en) * | 2019-08-26 | 2021-03-04 | Rootpath Genomics, Inc. | Compositions and methods for producing adeno-associated viral vectors |
WO2021041485A1 (en) | 2019-08-26 | 2021-03-04 | Voyager Therapeutics, Inc. | Controlled expression of viral proteins |
EP4031148A1 (en) | 2019-09-16 | 2022-07-27 | uniQure IP B.V. | Targeting misspliced transcripts in genetic disorders |
CA3168055A1 (en) | 2020-02-21 | 2021-08-26 | Emmanuel John Simons | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
WO2021195491A2 (en) * | 2020-03-26 | 2021-09-30 | Asklepios Biopharmaceutical, Inc. | Inducible promoter for viral vector production |
KR20220161297A (en) | 2020-04-02 | 2022-12-06 | 유니큐어 바이오파마 비.브이. | new cell line |
EP4127135A1 (en) | 2020-04-02 | 2023-02-08 | uniQure biopharma B.V. | Dual bifunctional vectors for aav production |
JP2023521347A (en) | 2020-04-07 | 2023-05-24 | ユニキュアー アイピー ビー.ブイ. | Genetic constructs and uses thereof for silencing angiopoietin-like 3 (ANGPTL3) |
BR112022020753A2 (en) | 2020-04-15 | 2022-12-20 | Voyager Therapeutics Inc | TAU-BINDING COMPOUNDS |
KR20230093241A (en) | 2020-07-27 | 2023-06-27 | 보이저 테라퓨틱스, 인크. | Compositions and methods for the treatment of neurological disorders associated with glucosylceramides beta deficiency |
US20230285596A1 (en) | 2020-07-27 | 2023-09-14 | Voyager Therapeutics, Inc | Compositions and methods for the treatment of niemann-pick type c1 disease |
EP4192514A1 (en) | 2020-08-06 | 2023-06-14 | Voyager Therapeutics, Inc. | Cell culture medium for use in producing gene therapy products in bioreactors |
WO2022187548A1 (en) | 2021-03-03 | 2022-09-09 | Voyager Therapeutics, Inc. | Controlled expression of viral proteins |
TW202246516A (en) | 2021-03-03 | 2022-12-01 | 美商航海家醫療公司 | Controlled expression of viral proteins |
CN115427561A (en) | 2021-03-09 | 2022-12-02 | 辉大(上海)生物科技有限公司 | Engineered CRISPR/Cas13 systems and uses thereof |
WO2022214635A1 (en) | 2021-04-08 | 2022-10-13 | Stichting Vu | Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders |
WO2022253955A2 (en) | 2021-06-02 | 2022-12-08 | Uniqure Biopharma B.V. | Insect cell production of parvoviral vectors with modified capsid proteins |
AU2022285138A1 (en) | 2021-06-02 | 2023-11-30 | Uniqure Biopharma B.V. | Adeno-associated virus vectors modified to bind high-density lipoprotein |
CN117836010A (en) | 2021-06-21 | 2024-04-05 | 优尼科生物制药有限公司 | Improved cleavage procedure |
EP4359525A1 (en) | 2021-06-21 | 2024-05-01 | uniQure biopharma B.V. | Gene constructs for silencing alpha-synuclein and uses thereof |
WO2023283962A1 (en) | 2021-07-16 | 2023-01-19 | Huigene Therapeutics Co., Ltd. | Modified aav capsid for gene therapy and methods thereof |
WO2023025920A1 (en) | 2021-08-26 | 2023-03-02 | Uniqure Biopharma B.V. | Insect cell-produced high potency aav vectors with cns-tropism |
WO2023091949A2 (en) | 2021-11-17 | 2023-05-25 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency |
WO2023147374A2 (en) | 2022-01-25 | 2023-08-03 | Voyager Therapeutics, Inc. | Baculovirus expression system |
CN114703203A (en) * | 2022-02-11 | 2022-07-05 | 上海渤因生物科技有限公司 | Baculovirus vectors and uses thereof |
WO2023198702A1 (en) | 2022-04-12 | 2023-10-19 | Uniqure Biopharma B.V. | Nucleic acid regulation of c9orf72 |
WO2023198663A1 (en) | 2022-04-12 | 2023-10-19 | Uniqure Biopharma B.V. | Nucleic acid regulation of snca |
WO2023198662A1 (en) | 2022-04-12 | 2023-10-19 | Uniqure Biopharma B.V. | Novel systems for nucleic acid regulation |
WO2023198745A1 (en) | 2022-04-12 | 2023-10-19 | Uniqure Biopharma B.V. | Nucleic acid regulation of apoe |
WO2023240236A1 (en) | 2022-06-10 | 2023-12-14 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of spinal muscular atrophy related disorders |
WO2024054983A1 (en) | 2022-09-08 | 2024-03-14 | Voyager Therapeutics, Inc. | Controlled expression of viral proteins |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US5871974A (en) * | 1990-09-28 | 1999-02-16 | Ixsys Inc. | Surface expression libraries of heteromeric receptors |
NZ308772A (en) | 1995-05-17 | 1999-04-29 | Du Pont | Recombinant baculovirus insecticides |
FR2774699B1 (en) | 1997-11-17 | 2003-10-03 | Rhone Poulenc Rorer Sa | METHOD FOR REDUCING HOMOLOGATED RECOMBINATION EVENTS |
US6103526A (en) | 1998-10-08 | 2000-08-15 | Protein Sciences Corporation | Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using |
ES2311464T3 (en) | 1999-06-24 | 2009-02-16 | The University Of British Columbia | THERAPY WITH LIPOPROTEIN LIPASA VARIANTE (LPL). |
AU781478B2 (en) * | 1999-08-20 | 2005-05-26 | Johns Hopkins University School Of Medicine, The | Methods and compositions for the construction and use of fusion libraries |
JP2003526377A (en) * | 2000-03-14 | 2003-09-09 | ニユーロロジクス・インコーポレーテツド | Production of chimeric capsid vector |
US20030129203A1 (en) * | 2001-08-27 | 2003-07-10 | Nautilus Biotech S.A. | Mutant recombinant adeno-associated viruses |
US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
CA2467959C (en) | 2001-11-09 | 2009-03-10 | Robert M. Kotin | Production of adeno-associated virus in insect cells |
CA2369985A1 (en) * | 2002-01-18 | 2003-07-18 | Duke University | Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
AU2003213060A1 (en) * | 2002-02-14 | 2003-09-04 | Novavax, Inc. | Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
WO2003074714A1 (en) | 2002-03-05 | 2003-09-12 | Stichting Voor De Technische Wetenschappen | Baculovirus expression system |
DE10260805A1 (en) | 2002-12-23 | 2004-07-22 | Geneart Gmbh | Method and device for optimizing a nucleotide sequence for expression of a protein |
US20070275449A1 (en) * | 2003-10-15 | 2007-11-29 | Vector Gene Technology Company Ltd. | Method for Large-Scale Production, Isolation, Purification and the Uses of Multi-Type Recombinant Adeno-Associated Virus Vectors |
US20060166363A1 (en) * | 2004-01-27 | 2006-07-27 | Sergei Zolotukhin | Modified baculovirus expression system for production of pseudotyped rAAV vector |
WO2006015789A2 (en) | 2004-08-03 | 2006-02-16 | Geneart Ag | Method for modulating gene expression by modifying the cpg content |
WO2007046703A2 (en) | 2005-10-20 | 2007-04-26 | Amsterdam Molecular Therapeutics B.V. | Improved aav vectors produced in insect cells |
EP1981548A4 (en) * | 2006-01-20 | 2010-03-24 | Univ North Carolina | Enhanced production of infectious parvovirus vectors in insect cells |
EP3023500B1 (en) | 2006-06-21 | 2020-02-12 | uniQure IP B.V. | Insect cells for the production of aav vectors |
PT2173888T (en) * | 2007-07-26 | 2016-11-17 | Uniqure Ip Bv | Baculoviral vectors comprising repeated coding sequences with differential codon biases |
-
2008
- 2008-07-25 PT PT87790580T patent/PT2173888T/en unknown
- 2008-07-25 SI SI200832065T patent/SI3093345T1/en unknown
- 2008-07-25 WO PCT/NL2008/050512 patent/WO2009014445A2/en active Application Filing
- 2008-07-25 PL PL16176100T patent/PL3093345T3/en unknown
- 2008-07-25 KR KR1020107003963A patent/KR101597695B1/en active IP Right Grant
- 2008-07-25 DK DK08779058.0T patent/DK2173888T3/en active
- 2008-07-25 DK DK16176100.2T patent/DK3093345T3/en active
- 2008-07-25 EP EP08779058.0A patent/EP2173888B1/en active Active
- 2008-07-25 US US12/670,780 patent/US8697417B2/en active Active
- 2008-07-25 PL PL08779058T patent/PL2173888T3/en unknown
- 2008-07-25 EA EA201070184A patent/EA022169B1/en not_active IP Right Cessation
- 2008-07-25 AU AU2008279883A patent/AU2008279883B2/en active Active
- 2008-07-25 MX MX2010000944A patent/MX2010000944A/en active IP Right Grant
- 2008-07-25 BR BRPI0814459-1A patent/BRPI0814459B1/en active IP Right Grant
- 2008-07-25 EP EP19170381.8A patent/EP3561063A1/en active Pending
- 2008-07-25 JP JP2010518140A patent/JP5634262B2/en active Active
- 2008-07-25 CN CN200880108079.2A patent/CN101868547B/en active Active
- 2008-07-25 HU HUE08779058A patent/HUE029744T2/en unknown
- 2008-07-25 EP EP16176100.2A patent/EP3093345B8/en active Active
- 2008-07-25 NZ NZ582881A patent/NZ582881A/en unknown
- 2008-07-25 ES ES08779058.0T patent/ES2602585T3/en active Active
- 2008-07-25 CA CA2694406A patent/CA2694406C/en active Active
- 2008-07-25 SI SI200831676A patent/SI2173888T1/en unknown
-
2010
- 2010-01-26 IL IL203535A patent/IL203535A/en active IP Right Grant
- 2010-10-14 HK HK10109722.4A patent/HK1143185A1/en unknown
-
2014
- 2014-02-27 US US14/192,101 patent/US9580691B2/en active Active
- 2014-07-14 JP JP2014144592A patent/JP2014239686A/en active Pending
-
2015
- 2015-09-30 US US14/870,614 patent/US10190098B2/en active Active
-
2018
- 2018-12-11 US US16/216,775 patent/US11306291B2/en active Active
-
2022
- 2022-04-15 US US17/722,275 patent/US20220251520A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3093345T3 (en) | BACULOVIRUS VECTORS INCLUDING REPEATED CODING SEQUENCES WITH DIFFERENTIAL PREFERRED CODES | |
BRPI0918426A2 (en) | multi-colored codes | |
DK2115143T3 (en) | BUTTIAUXELLA SP.-PHYTHASE VARIETIES WITH CHANGED PROPERTIES | |
ZA201009013B (en) | Bronchoalveolar lavage catheter assembly | |
DK3484076T3 (en) | Computationally efficient convolutional coding with rate matching | |
BRPI0911849A2 (en) | sunscreens | |
BRPI0816900A2 (en) | User Equipment | |
DE602005012822D1 (en) | NMR-RF-COILS WITH SHIFTED MOVABLE CAPACITY-TAPES | |
DK2122102T3 (en) | Flexible curtain design | |
DE602008003253D1 (en) | sliding element | |
BRPI0916202A2 (en) | umbilical cord | |
BRPI0820420A2 (en) | Tubing | |
DE502006003047D1 (en) | rubber sleeve | |
PT3093345T (en) | Baculoviral vectors comprising repeated coding sequences with differential codon biases | |
GB0808017D0 (en) | shRHA sequences | |
ES1065910Y (en) | LINEAR CARP | |
DK200700225U1 (en) | Chemical compound with useful properties | |
ES1068259Y (en) | TUBULAR CELOSIA | |
ITCH20060019A1 (en) | CODE DETECTOR-SENSOR | |
UY3746Q (en) | PROFILE | |
UA17337S (en) | PROFILE | |
UA15442S (en) | PROFILE | |
UY3748Q (en) | PROFILE | |
UA15441S (en) | PROFILE | |
UA15440S (en) | PROFILE |